Abstract
Heavy alkaline earth metals offer radionuclides which are promising candidates for radiopharmaceutical applications like the γ-emitter barium-131 for diagnosis or the alpha-emitters radium-223/-224 – with similar chemical properties to barium – for targeted alpha-particle therapy. However, there is a lack of suitable chelation agents, especially for these metal ions. A series of calix[4]crown-6 derivatives with perfluoroalkylsulfonylcarboxamide functions (R$_{F}$ = CF$_3$, C$_2$F$_5$, $i$-C$_3$F$_7$, $n$-C$_4$F$_9$) was synthesized to serve as cage-like chelators for Ba$^{2+}$ and Ra$^{2+}$ to determine the complexation behaviour. These functional ligands are deprotonated even at slightly acidic pH due to the intense electron-withdrawing effect of the sulfonamide groups. The obtained ligands were easily converted to the desired barium complexes as well as into calix-crown compounds containing two sodium ions. DFT calculations were used to discover the binding behaviour of the metal ions with the desired ligands and the influence of the different donor groups from the chelating moiety of the calixarenes with respect to different pH. Radiolabeling procedures with the radionuclides barium-133 and radium-224 as [$^{133}$Ba]BaCl$_{2}$ and [$^{224}$Ra]Ra(NO$_3$)$_2$ were performed to determine association constant values between 4.1 and 8.2 for the appropriate M2+ complexes using a two-phase extraction procedure. A stability test using physiological Ca$^{2+}$ solution showed a minor release of approx. 1–7% of the central ions (Ba$^{2+}$ respectively Ra$^{2+}$) from the complexes.
Reissig, Falco